Gensight Biologics

This study is testing an experimental gene therapy called GS010 for people with a rare, inherited form of vision loss called ND4 Leber Hereditary Optic Neuropathy (LHON). Researchers are injecting the therapy into both eyes of participants to see if it can improve vision and how …